Jasper Therapeutics Statistics

Total Valuation

JSPR has a market cap or net worth of $323.58 million. The enterprise value is $233.15 million.

Market Cap	323.58M
Enterprise Value	233.15M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

JSPR has 15.00 million shares outstanding. The number of shares has increased by 58.22% in one year.

Current Share Class	15.00M
Shares Outstanding	15.00M
Shares Change (YoY)	+58.22%
Shares Change (QoQ)	+0.09%
Owned by Insiders (%)	1.28%
Owned by Institutions (%)	68.02%
Float	10.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.87
P/TBV Ratio	3.87
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.61, with a Debt / Equity ratio of 0.02.

Current Ratio	7.61
Quick Ratio	7.44
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -71.46% and return on invested capital (ROIC) is -46.94%.

Return on Equity (ROE)	-71.46%
Return on Assets (ROA)	-40.92%
Return on Capital (ROIC)	-46.94%
Revenue Per Employee	n/a
Profits Per Employee	-$1.41M
Employee Count	45
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +318.27% in the last 52 weeks. The beta is 2.19, so JSPR's price volatility has been higher than the market average.

Beta (5Y)	2.19
52-Week Price Change	+318.27%
50-Day Moving Average	21.46
200-Day Moving Average	21.97
Relative Strength Index (RSI)	48.67
Average Volume (20 Days)	181,869

Short Selling Information

The latest short interest is 2.06 million, so 13.70% of the outstanding shares have been sold short.

Short Interest	2.06M
Short Previous Month	1.94M
Short % of Shares Out	13.70%
Short % of Float	20.48%
Short Ratio (days to cover)	9.32

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-68.68M
Pretax Income	-63.93M
Net Income	-63.53M
EBITDA	-67.27M
EBIT	-68.68M
Earnings Per Share (EPS)	-$4.67

Full Income Statement

Balance Sheet

The company has $92.50 million in cash and $2.07 million in debt, giving a net cash position of $90.43 million or $6.03 per share.

Cash & Cash Equivalents	92.50M
Total Debt	2.07M
Net Cash	90.43M
Net Cash Per Share	$6.03
Equity (Book Value)	83.68M
Book Value Per Share	5.58
Working Capital	82.35M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$57.95 million and capital expenditures -$686,000, giving a free cash flow of -$58.63 million.

Operating Cash Flow	-57.95M
Capital Expenditures	-686,000
Free Cash Flow	-58.63M
FCF Per Share	-$3.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JSPR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-58.22%
Shareholder Yield	-58.22%
Earnings Yield	-19.63%
FCF Yield	-18.12%

Analyst Forecast

The average price target for JSPR is $73.38, which is 240.20% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$73.38
Price Target Difference	240.20%
Analyst Consensus	Strong Buy
Analyst Count	11
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-13.39%

Stock Forecasts

Stock Splits

The last stock split was on January 4, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Jan 4, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1